BICO Group AB Class B (SE:BICO)
:BICO
Want to see SE:BICO full AI Analyst Report?
BICO Stock Chart & Stats
kr18.16
-kr2.08(-4.75%)
At close: 4:00 PM EST
kr18.16
-kr2.08(-4.75%)
Day’s Range― - ―
52-Week Rangekr15.30 - kr42.46
Previous CloseN/A
Volume245.45K
Average Volume (3M)288.59K
Market Cap
kr1.28B
Enterprise Valuekr1.20B
Total Cash (Recent Filing)kr744.30M
Total Debt (Recent Filing)kr690.60M
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Aug 25, 2026EPS Estimate
-0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.97
Shares Outstanding69,074,900
10 Day Avg. Volume264,488
30 Day Avg. Volume288,586
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.85
Price to Sales (P/S)0.99
P/FCF Ratio26.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.35
Revenue Forecast (FY)kr1.57B
Bulls Say, Bears Say
Bulls Say
Improved Gross MarginA sustained gross margin lift to ~45% implies improved product mix or pricing power in core instruments, consumables and services. This structural margin expansion increases the potential for durable operating leverage and higher cash conversion if management sustains cost control and recurring revenue growth.
Strengthened Liquidity And RunwayPro forma cash of ~SEK 670m after settling convertible debt materially reduces near-term refinancing risk and funds R&D, commercialization and bolt-on M&A. This improved liquidity gives the company a multi-quarter runway to execute BICO 2.0 initiatives without immediate pressure to cut strategic investments.
Shift To Lab Automation, AI/software And PartnershipsPrioritizing software, AI-enabled workflows and strategic partnerships supports higher recurring revenue and customer stickiness. Durable benefits include differentiated commercial offerings, upsell of consumables/services, and potential margin resilience as software and automation scale versus cyclical instrument sales.
Bears Say
Deep, Recurring Losses And Volatile ProfitabilityA very large negative net margin (~-70%) and recurring losses indicate ongoing structural profitability issues. Over the medium term this erodes retained earnings, limits reinvestment capacity, and raises the bar for sustained operational improvement before cash generation and returns normalize.
Eroding Equity Base And Moderate LeverageA materially reduced equity base combined with debt-to-equity near 0.86 lowers financial flexibility. This makes the company more sensitive to earnings volatility and increases refinancing and covenant risks, constraining strategic options like aggressive M&A or higher R&D spending if losses persist.
Structural Demand Headwinds For Instrument SalesEnd-market pressures—academic funding cuts and cautious customer CapEx—are structural near-term constraints on instrument-heavy revenue. These reduce addressable demand for core hardware, lengthen sales cycles, and can depress consumables and service growth unless product mix shifts toward less cyclical software/automation revenues.
BICO Group AB Class B News
BICO FAQ
What was BICO Group AB Class B’s price range in the past 12 months?
BICO Group AB Class B lowest stock price was kr15.30 and its highest was kr42.46 in the past 12 months.
What is BICO Group AB Class B’s market cap?
BICO Group AB Class B’s market cap is kr1.28B.
When is BICO Group AB Class B’s upcoming earnings report date?
BICO Group AB Class B’s upcoming earnings report date is Aug 25, 2026 which is in 101 days.
How were BICO Group AB Class B’s earnings last quarter?
BICO Group AB Class B released its earnings results on Apr 29, 2026. The company reported -kr1.725 earnings per share for the quarter, missing the consensus estimate of -kr1 by -kr0.725.
Is BICO Group AB Class B overvalued?
According to Wall Street analysts BICO Group AB Class B’s price is currently Overvalued.
Does BICO Group AB Class B pay dividends?
BICO Group AB Class B does not currently pay dividends.
What is BICO Group AB Class B’s EPS estimate?
BICO Group AB Class B’s EPS estimate is -0.75.
How many shares outstanding does BICO Group AB Class B have?
BICO Group AB Class B has 69,074,900 shares outstanding.
What happened to BICO Group AB Class B’s price movement after its last earnings report?
BICO Group AB Class B reported an EPS of -kr1.725 in its last earnings report, missing expectations of -kr1. Following the earnings report the stock price went up 9.989%.
Which hedge fund is a major shareholder of BICO Group AB Class B?
Currently, no hedge funds are holding shares in SE:BICO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BICO Group AB Class B
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.
BICO Company Deck
BICO Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: the company executed its strategic repositioning (BICO 2.0), strengthened its cash position through a EUR 40m bond issuance, reduced debt and demonstrated a clear Q4 recovery with strong margins and Biosero momentum. However, full-year financials were weak (organic sales -8%, adjusted EBITDA only SEK 5m, Lab Automation full-year decline -26% and negative EBITDA), and the business faced notable macro headwinds (US academia funding cuts, FX pressure and cautious CapEx). Product launches, partnerships and AI-enabled offerings provide a foundation for growth, but near-term performance still reflects industry and legacy operational challenges.View all SE:BICO earnings summariesTechnical Analysis
CellaVision AB
―
Senzime AB
―
Bactiguard Holding AB
―
C-Rad AB Class B
―
Sedana Medical AB
―
Options Prices
Currently, No data available
---